Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Baudax Bio, Inc.
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
May 12, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio to Present at the Sidoti Virtual Investor Conference
May 03, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Closing of $4 Million Public Offering
May 01, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Pricing of $4 Million Public Offering
April 26, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
April 25, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
April 24, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
March 27, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
February 23, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
January 24, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
December 08, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Closing of $5 Million Public Offering
December 06, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Pricing of $5 Million Public Offering
December 02, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces 1-for-40 Reverse Stock Split
November 30, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights
November 08, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.